Truly empowering patients to keep themselves well, manage their conditions and stay out of hospitals requires health professionals to understand the needs, the skills, and the confidence of the individual patient they are working with
Portland, Ore (PRWEB UK) 19 May 2016
NHS England has expanded its license of the Patient Activation Measure to cover nearly 2 million people through allocation of PAM licenses to around 40 affiliated organizations over the next few months. The licenses will enable local NHS organizations and their partners to measure patient activation, and tailor interventions and support based upon a person’s self-management ability.
“Truly empowering patients to keep themselves well, manage their conditions and stay out of hospitals requires health professionals to understand the needs, the skills, and the confidence of the individual patient they are working with,” said Dr. Alf Collins, NHS England national Clinical Advisor. “The Patient Activation Measure shows real promise as a tool to achieve this, and I look forward to seeing how more local areas can use it in innovative ways to provide care which is more person-centered, delivering better outcomes for patients and better value for taxpayers,” he added.
Following trials of PAM with six areas through local clinical commissioning groups (CCGs), it is expected that measuring and improving patient activation will lead to patients enjoying better experiences of care and outcomes, making more positive choices about their health and wellbeing, and experiencing fewer unplanned hospital admissions.
“In Sheffield, we have been finding PAM a really useful tool for tailoring our level of support and health coaching to match a person’s needs,” said Dr. Ollie Hart, GP and clinical lead for person-centered care at Sheffield CCG. “By embedding it in our processes for supporting people with diabetes, we have gained a better understanding of patients’ needs and behaviors, allowing us to ensure that resources – particularly staff time – are being used more effectively for their benefit,” he added.
“Gains in patient self-care are central to the NHS England Five Year Forward plan and key to improving upon the efficiency and high quality of care for which England is known,” said Chris Delaney, CEO of Insignia Health. “It’s been proven time and again, and seen as well in early results in England, that measuring patient activation and properly tailoring care plans to activation level improves health outcomes,” he added.
# # #
About Insignia Health: Insignia Health is the gold standard provider of patient activation solutions that pinpoint population health risk, improve health outcomes, reduce healthcare costs and increase patient/member satisfaction. Our Patient Activation Measure® (PAM®) is a predictive powerhouse backed by over a decade of health activation research and insight gained from supporting hospitals, health systems, health plans, life science firms and government agencies around the globe. Our products and services help organizations exceed performance objectives by measuring activation and tailoring care programs to specific activation levels. We strive to lessen disease, illness burden and premature deaths around the world. Insignia Health is headquartered in Portland, Oregon. Visit http://www.insigniahealth.com, email info(at)insigniahealth(dot)com or follow us on Facebook and Twitter.